← SynDRA
ONVANSERTIB
SynDRA canonical compound SYN0026647 — structure-anchored drug synonym record
| Primary target(s) | PLK1 |
|---|
| Mechanism of action | PLK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLK inhibitor
- PLK1 INHIBITOR
- Serine/threonine-protein kinase PLK1 inhibitor
- FLT3 INHIBITOR
- PLK2 INHIBITOR
- PLK3 INHIBITOR
Cross-references
Synonyms
- NMS-1286937
- NMS-P937
- PCM-075
- NMS 1286937
- PCM 075
- POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
- RefChem:928230
- 'PLK1 Inhibitor PCM-075
- PLK-1 Inhibitor PCM-075
- DTXCID001510165
- Polo-like Kinase 1 Inhibitor PCM-075
- NMS P937
- NMS-P937 (NMS1286937)
- Onvansertib free base
- Onvansertib [USAN]
- MFCD26793840
- Onvansertib (USAN)
- UNII-67RM91WDHQ
- NMS1286937
- C24H27F3N8O3
- ONVANSERTIB [INN]
- Onvansertib (NMS-P937)
- ONVANSERTIB [WHO-DD]
- GTPL7918
- orb1300940
- SCHEMBL1228019
- SCHEMBL29379736
- NMS-P 937
- GLXC-15790
- HMS3653G04
- HMS3673E21
- EX-A1590
- BDBM50343559
- NSC781344
- NSC800806
- s7255
- WHO 11172
- AKOS027253333
- CCG-269924
Look up ONVANSERTIB in the interactive SynDRA portal →